Watchlist
New life for a well proven product
− Highly effective product with a vast addressable market
− Reinvigorated strategy and new (proven) management
− Credible plan for high growth path to profitability
Valuation A$3.28
Current price A$0.92
Market cap A$79m
Cash on hand A$24.7m (end FY23)
Upcoming Catalysts and Newsflow
Period
FY24e Next Generation Penthrox inhaler launch
FY24? Potential US partner for Penthrox announce
Another Positive Study, page-147
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.13M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.5¢ | $62.23K | 136.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4615 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 23423 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |